Family Med Medical News about Hepatoblastoma

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Long-term Treatment Results of Hepatoblastoma at a Single Institution in Taiwan
Journal of Pediatric Hematology/Oncology, 11/06/09

Hou JY et al. – The commonest toxicity was febrile neutropenia. There was no cardiotoxicity event. In conclusion, with sequential combination of surgery and chemotherapy, the treatment results for hepatoblastoma were satisfactory as compared with other groups.

<< Previous
Prevalence and distribution of melanocytic naevi on the scalp: a...

Next >>
Satraplatin: leading the new generation of oral platinum agents

Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge
Diagnostic Pathology, 11/17/09 Relevance Score: 87%

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09 Relevance Score: 87%

Hepatoblastoma, cisplatin, and ototoxicity
Cancer, 10/12/09 Relevance Score: 83%